Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator
Author(s) -
Ajmal Gardiwal,
Hong Yu,
H. Oswald,
Ulrich Luesebrink,
A. Ludwig,
A. M. Pichlmaier,
H. Drexler,
G. Klein
Publication year - 2008
Publication title -
ep europace
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.119
H-Index - 102
eISSN - 1532-2092
pISSN - 1099-5129
DOI - 10.1093/europace/eun019
Subject(s) - medicine , cardiology , heart failure , ejection fraction , ventricular tachycardia , implantable cardioverter defibrillator , ventricular fibrillation , clinical endpoint , atrial fibrillation , fibrillation , qrs complex , proportional hazards model , population , randomized controlled trial , environmental health
There is increasing evidence that right ventricular (RV) pacing may have detrimental effects by increasing morbidity and mortality for heart failure in implantable cardioverter-defibrillator (ICD) patients. In this study we prospectively tested the hypothesis that cumulative RV pacing increases ventricular tachycardia/ventricular fibrillation (VT/VF) occurrence (primary endpoint) and hospitalization and mortality for heart failure (secondary endpoint) in a predominantly secondary prophylactic ICD patient population.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom